Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
39
pubmed:dateCreated
2009-9-17
pubmed:abstractText
We used 2-deoxy-2-[(18)F] fluoro-D-glucose (FDG) positron emission tomography (PET) to evaluate the FDG uptake in patients with soft tissue sarcoma (STS). Treatment effect was assessed with regard to prediction of therapy outcome.
pubmed:language
ger
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
1439-4413
pubmed:author
pubmed:copyrightInfo
Georg Thieme Verlag KG Stuttgart, New York.
pubmed:issnType
Electronic
pubmed:volume
134
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1922-6
pubmed:meshHeading
pubmed-meshheading:19760551-Adult, pubmed-meshheading:19760551-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:19760551-Disease Progression, pubmed-meshheading:19760551-Doxorubicin, pubmed-meshheading:19760551-Etoposide, pubmed-meshheading:19760551-Female, pubmed-meshheading:19760551-Fluorodeoxyglucose F18, pubmed-meshheading:19760551-Humans, pubmed-meshheading:19760551-Ifosfamide, pubmed-meshheading:19760551-Male, pubmed-meshheading:19760551-Middle Aged, pubmed-meshheading:19760551-Positron-Emission Tomography, pubmed-meshheading:19760551-Radiopharmaceuticals, pubmed-meshheading:19760551-Remission Induction, pubmed-meshheading:19760551-Sarcoma, pubmed-meshheading:19760551-Soft Tissue Neoplasms, pubmed-meshheading:19760551-Treatment Outcome, pubmed-meshheading:19760551-Young Adult
pubmed:year
2009
pubmed:articleTitle
[Positron emission tomography as a tool for early prediction of therapy outcome in soft tissue sarcoma].
pubmed:affiliation
Abteilung Innere Medizin V (Hämatologie, Onkologie und Rheumatologie), Medizinische Klinik, Universitätsklinikum Heidelberg, Im Neuenheimer Feld 410, 69120 Heidelberg. mail@berndkasper.de
pubmed:publicationType
Journal Article, English Abstract, Case Reports, Evaluation Studies